"Clinical Research Facility specializing in examining new medications in the mental health and neurological field of study."

During the past decade, Woodland Research Northwest conducted 51 clinical trials. In the 10-year time frame, 51 clinical trials started and 26 clinical trials were completed, i.e. on average, 51% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 24 clinical trials were completed. i.e. 96% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Woodland Research Northwest" #1 sponsor was "Jazz Pharmaceuticals" with 4 trials, followed by "Mitsubishi Tanabe Pharma America Inc." with 4 trials sponsored, "Naurex, Inc, an affiliate of Allergan plc" with 4 trials sponsored, "Sunovion" with 4 trials sponsored and "Hoffmann-La Roche" with 4 trials sponsored. Other sponsors include 28 different institutions and companies that sponsored additional 30 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Woodland Research Northwest" #1 collaborator was "Celerion" with 4 trials as a collaborator, "H. Lundbeck A/S" with 3 trials as a collaborator, "Cognitive Research Corporation" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Gedeon Richter Ltd." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Woodland Research Northwest" are "Schizophrenia" (13 trials), "Depressive Disorder, Major" (5 trials), "Tobacco Use" (5 trials), "ALS" (3 trials) and "Bipolar I Disorder" (3 trials). Many other conditions were trialed in "Woodland Research Northwest" in a lesser frequency.

Most popular intervention types in "Woodland Research Northwest" are "Drug" (47 trials), "Other" (9 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (27 trials), "MT-1186" (4 trials), "Rapastinel" (4 trials), "Brexpiprazole" (3 trials) and "SEP-363856" (3 trials). Other intervention names were less common.

The vast majority of trials in "Woodland Research Northwest" are 52 trials for "All" genders.

Currently, there are NaN active trials in "Woodland Research Northwest". undefined are not yet recruiting, 9 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 35 completed trials in Woodland Research Northwest, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Woodland Research Northwest, 5 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".